Skip to main content
Sunday
January 29, 2023
Sign In
Subscribe
Home
Economy
Aviation
Bazaar
Budget
Industry
NBR
RMG
Corporates
Stocks
Analysis
World+Biz
Sports
Features
Book Review
Brands
Earth
Explorer
Fact Check
Family
Food
Game Reviews
Good Practices
Habitat
Humour
In Focus
Luxury
Mode
Panorama
Pursuit
Wealth
Wellbeing
Wheels
Epaper
More
Subscribe
Videos
Thoughts
Splash
Bangladesh
Supplement
Infograph
Archive
COVID-19
Games
Long Read
Interviews
Offbeat
Podcast
Quiz
Tech
Trial By Trivia
Magazine
বাংলা
SUNDAY,
JANUARY 29, 2023
Oxford-AstraZeneca vaccine
Covid-19 in Bangladesh
Bangladesh gets over 8m AstraZeneca jabs from Japan, UK
The government has so far achieved 32% of the overall vaccination target
Coronavirus chronicle
US to share up to 60 mln AstraZeneca vaccine doses globally
Coronavirus chronicle
Australia to continue AstraZeneca vaccine rollout, review EU findings
Coronavirus chronicle
Questions about AstraZeneca jab linger
Coronavirus chronicle
Covax expects full vaccine supplies from India's Serum in May, says Unicef
Analysis
Missteps could mar long-term credibility of AstraZeneca shot
Coronavirus chronicle
AstraZeneca may have provided incomplete efficacy data from latest Covid-19 trial: NIAID
Coronavirus chronicle
AstraZeneca vaccine 79% effective in US trial
Analysis
How worried should we be about reports of blood clots and AstraZeneca's vaccine?
Coronavirus chronicle
Health experts pore over AstraZeneca safety data as Europe reels from vaccine suspensions
Coronavirus chronicle
Netherlands halts use of AstraZeneca Covid-19 vaccine
Coronavirus chronicle
Spanish regions halt AstraZeneca shots over blood clot concerns
Coronavirus chronicle
No clotting case in India after Oxford dose
Show More